
Cognizin® Citicoline
Attention and mental energy.
What it is
A naturally occurring compound found in every cell, which the body uses to build brain cell membranes and produce acetylcholine, a neurotransmitter involved in attention and memory. Cognizin® is the branded, clinically studied form.
What the research shows
Originally developed in Japan in the 1970s, citicoline has been studied for over 50 years. Randomised, double-blind, placebo-controlled trials in healthy adults have looked specifically at attention.
McGlade et al. (2012) gave 250-500mg/day to 60 healthy women for 28 days and measured attention on a continuous performance test; the citicoline groups made fewer attention errors than placebo1.
McGlade et al. (2019) repeated this in 75 healthy adolescent males and reported improved attention and psychomotor speed2.
Bruce et al. (2014) tested a drink combining citicoline with caffeine in 60 healthy adults and found faster reaction times, fewer errors on a go/no-go task, and EEG markers associated with sustained attention3. A 2025 trial of 148 healthy adults reported improvements in sustained attention, reaction time and processing speed after 12 weeks at 500mg/day4.
Why it's in GC18
Golf is a game of sustained attention with long gaps between shots. Citicoline is the ingredient in the formula most directly studied for exactly that. GC18 contains 500mg per serving.
Key study
- Study
- Bruce et al. 2014
- Design
- Randomised, double-blind, placebo-controlled
- Participants
- 60 healthy adults
- Intervention
- Citicoline + caffeine beverage vs placebo
- Measured
- Reaction time, go/no-go errors, EEG
- Result
- Faster reactions, fewer errors, increased sustained-attention markers
Honest note: Most citicoline attention studies used daily dosing over several weeks. Acute single-dose research in healthy adults is more limited.





